RT Journal Article
SR Electronic
T1 Fluorodeoxyglucose–Positron-Emission Tomography Imaging of Head and Neck Squamous Cell Cancer
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 598
OP 604
DO 10.3174/ajnr.A1760
VO 31
IS 4
A1 R.M. Subramaniam
A1 M. Truong
A1 P. Peller
A1 O. Sakai
A1 G. Mercier
YR 2010
UL http://www.ajnr.org/content/31/4/598.abstract
AB SUMMARY: The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC. CRcomplete responseDCTcontrast enhanced diagnostic CT18Ffluorine-18FDGfluorodeoxyglucoseFDG-PETfluorodeoxyglucose–positron-emission tomographyFNAfine-needle aspirationGTVgross tumor volumeHNSCChead and neck squamous cell carcinomasIMRTintensity modulated radiation therapyMmetastasisNnodePETpositron-emission tomographyPTVplanning target volumeRDresidual diseaseSCCsquamous cell carcinomaSUVstandard uptake valueSUVmaxmaximum SUVTtumor